IA
RMD icon

Inspire Advisors’s ResMed RMD Stock Holding History

Inspire Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.2M Buy
5,336
+225
+4% +$56.1K 0.1% 162
2025
Q4 		$1.23M Sell
5,111
-330
-6% -$84.4K 0.11% 132
2025
Q3 		$1.49M Sell
5,441
-548
-9% -$150K 0.14% 111
2025
Q2 		$1.55M Buy
5,989
+3,316
+124% +$791K 0.16% 104
2025
Q1 		$598K Buy
2,673
+125
+5% +$29.2K 0.07% 209
2024
Q4 		$583K Sell
2,548
-206
-7% -$49.6K 0.07% 213
2024
Q3 		$672K Sell
2,754
-306
-10% -$68.4K 0.08% 169
2024
Q2 		$586K Buy
3,060
+56
+2% +$11.4K 0.08% 172
2024
Q1 		$595K Buy
3,004
+277
+10% +$50.8K 0.08% 174
2023
Q4 		$469K Buy
2,727
+1,174
+76% +$180K 0.07% 195
2023
Q3 		$230K Buy
1,553
+261
+20% +$47.2K 0.04% 240
2023
Q2 		$282K Buy
1,292
+159
+14% +$35.4K 0.05% 178
2023
Q1 		$248K Buy
1,133
+146
+15% +$31.7K 0.06% 157
2022
Q4 		$205K Buy
987
+71
+8% +$15.6K 0.05% 153
2022
Q3 		$200K Buy
+916
New +$208K 0.05% 129
2021
Q1 		– Sell
-350
Closed -$74K – 579
2020
Q4 		$74K Buy
+350
New +$69.8K 0.03% 178

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Inspire Advisors's RMD Position: Q1 2026 in Review

Inspire Advisors increased its ResMed (RMD) stake by 4.4% in Q1 2026, buying an estimated $56.1K and bringing the position to 5,336 shares worth $1.2M. The position accounts for 0.1% of the portfolio, ranked #162.

Inspire Advisors first reported a position in RMD in Q4 2020 and has held it in 16 quarters since. The position peaked at $1.55M in Q2 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Inspire Advisors held 5,336 shares of ResMed worth $1.2M as of Q1 2026.
  • Inspire Advisors bought 225 ResMed shares in Q1 2026, an estimated $56.1K.
  • ResMed made up 0.1% of Inspire Advisors's portfolio in Q1 2026, its #162 holding.
  • Inspire Advisors first reported a position in ResMed in Q4 2020 and has held it in 16 quarters since.
  • Inspire Advisors's ResMed position peaked at $1.55M in Q2 2025.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Inspire Advisors's 13F filing for Q1 2026, filed 15 May 2026.